-
公开(公告)号:US20220257731A1
公开(公告)日:2022-08-18
申请号:US17574847
申请日:2022-01-13
Applicant: University of Massachusetts
Inventor: Guangping Gao , Dominic Gessler
IPC: A61K38/50 , A61K48/00 , C12N15/00 , G01N33/50 , G01N33/06 , A61P25/28 , A61K9/00 , A61K45/06 , C12N7/00 , G01N33/66 , G01N33/68 , G01N33/84
Abstract: In some aspects, the disclosure relates to compositions and methods useful for the diagnosis and treatment of neurodegenerative diseases, such as leukodystrophies (e.g., Canavan Disease). In some embodiments, the methods comprise administering to a subject an N-acetylaspartate (NAA)-depleting agent or an N-acetylaspartate (NAA)-depleting agent based upon the subject's metabolic profile.
-
112.
公开(公告)号:US20220251602A1
公开(公告)日:2022-08-11
申请号:US17590337
申请日:2022-02-01
Applicant: University of Massachusetts
Inventor: Guangping Gao , Phillip Tai , Elisabet C. Mandon , Jianzhong Ai
IPC: C12N15/86
Abstract: In some aspects, the disclosure provides recombinant AAV and nucleic acid constructs having novel inverted terminal repeats (ITRs), cap, and/or rep genes. In some aspects, the disclosure relates to gene transfer methods using rAAVs described herein.
-
公开(公告)号:US20220235372A1
公开(公告)日:2022-07-28
申请号:US17581306
申请日:2022-01-21
Applicant: University of Massachusetts
Inventor: Guangping Gao , Phillip Tai , Manish Muhuri , Wei Zhan
IPC: C12N15/86 , C12N15/113 , A61K31/7088
Abstract: The disclosure, in some aspects, relates to nucleic acids, compositions and kits useful for gene therapy with reduced immune response to transgene products.
-
公开(公告)号:US20220186257A1
公开(公告)日:2022-06-16
申请号:US17602313
申请日:2020-04-10
Applicant: University of Massachusetts
Inventor: Guangping Gao , Alexander Brown
Abstract: Aspects of the disclosure relate to compositions and methods for multiplexed gene silencing in a cell or subject. In some embodiments, the disclosure provides an isolated nucleic acid or an rAAV encoding a transgene comprising a RNA-guided nuclease (RGN) operably linked to a first promoter, and a second promoter operably linked to a multi guide-RNA (multi-gRNA) expression cassette encoding one or more gRNAs targeting a gene associated with hypercholesterolemia or dyslipidemia. In some embodiments, the disclosure provides methods of treating a subject having hypercholesterolemia or dyslipidemia by administering the compositions.
-
公开(公告)号:US20220162570A1
公开(公告)日:2022-05-26
申请号:US17602353
申请日:2020-04-10
Applicant: University of Massachusetts , Clinic for Special Children
Inventor: Guangping Gao , Dan Wang , Jiaming Wang , kevin A Strauss
Abstract: In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHA protein, which is the E1-alpha subunit of the branched-chain alpha-keto acid (BCAA) dehydrogenase complex, in a subject. In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHB protein, which is the E1-beta subunit of the branched-chain alpha-keto acid (BCAA) dehydrogenase complex, in a subject. In some aspects the disclosure provides compositions and methods for promoting expression of functional BCKDHA and BCKDHB proteins, in a subject. In some embodiments, the disclosure provides methods of treating a subject having Maple Syrup Urine Disease (MSUD).
-
公开(公告)号:US20210261982A1
公开(公告)日:2021-08-26
申请号:US17051197
申请日:2019-04-29
Applicant: University of Massachusetts
Inventor: Alexander Brown , Guangping Gao
Abstract: Aspects of the disclosure relate to integration of a transgene packaged into recombinant adeno-associated virus (rAAV) by nuclease-assisted vector integration (NAVI).
-
公开(公告)号:US20210222196A1
公开(公告)日:2021-07-22
申请号:US17054794
申请日:2019-05-15
Applicant: University of Massachusetts
Inventor: Guangping Gao , Jun Xie
IPC: C12N15/86 , C12N15/113 , A61K35/76
Abstract: In some aspects the disclosure relates to recombinant adeno-associated vims (rAAV) vectors and rAAVs (e.g., viral particles) engineered to express a transgene comprising an inhibitory nucleic acid (e.g., an artificial miRNA, amiRNA) having a pri-miRNA scaffold and a guide strand that targets a human target gene.
-
公开(公告)号:US11060088B2
公开(公告)日:2021-07-13
申请号:US16076881
申请日:2017-02-10
Applicant: University of Massachusetts
Inventor: Guangping Gao , Yi Lu , Qiang Zheng , Xu Xun , Phillip D. Zamore , Phillip Tai
Abstract: The disclosure relates, in some aspects, to compositions and methods for treating corneal disease (e.g., corneal neovascularization. In some embodiments, the disclosure relates to rAAV-mediated delivery of an cornea-associated transgene to a subject. In some embodiments, the rAAV transduces the corneal tissue of a subject.
-
公开(公告)号:US20200231953A1
公开(公告)日:2020-07-23
申请号:US16775311
申请日:2020-01-29
Applicant: University of Massachusetts
Inventor: Guangping Gao , Phillip D. Zamore , Dan Wang
Abstract: The disclosure in some aspects relates to recombinant adeno-associated viruses having nuclease grafted to one or more capsid proteins. In some aspects, the disclosure relates to isolated AA V capsid proteins having terminally grafted nucleases and isolated nucleic acids encoding the same. Recent approaches to delivering nucleases to cells for gene editing have focused on delivering of expression vectors engineered to express the nucleases in target cells. However, these approaches have proved to be problematic in many instances due to genotoxicity resulting from to prolonged expression of gene editing system in vivo. To prevent such off-target genotoxicity due to prolonged presence of a gene editing system, several studies explored delivery of mRNA or protein instead of delivering the gene coding for the nucleases in cell culture.
-
公开(公告)号:US20200181651A1
公开(公告)日:2020-06-11
申请号:US16093575
申请日:2017-04-13
Applicant: University of Massachusetts
Inventor: Guangping Gao , Dan Wang
Abstract: The disclosure in some aspects relates to methods and compositions for repairing mutations (e.g., compound heterozygous mutations) that are widely found in patients having certain diseases (e.g., monogenic recessive diseases). In some aspects, the disclosure provides a method for targeted allelic exchange using recombinant gene editing complex.
-
-
-
-
-
-
-
-
-